Head to head
Assurant vs Chubb Ltd
Side-by-side on the measures that matter, with a plain-English read. Full detail: AIZ · CB
AIZ
Assurant
316.65+0.20%
1-year price shape — +42% over the period
Quant Rating C · 84/100
vs
CB
Chubb Ltd
371.63+0.41%
1-year price shape — +27% over the period
Quant Rating C · 73/100
1-year performance, rebased to 100
Chubb Ltd edges it on the scoreable measures. Chubb Ltd trades cheapest on trailing earnings; Chubb Ltd earns the most per share.
| AIZ | CB | |
|---|---|---|
| Snapshot | ||
| Sector | Insurance - Property & Casualty | -- |
| Last price | 316.65 | 371.63 |
| Change today | +0.20% | +0.41% |
| 1-year return | +42.1% | +27.0% |
| Market cap | $15.54B | $141.99B |
| 52-week range | 207.65 – 326.99 | 287.49 – 384.26 |
| Valuation | ||
| P/E (TTM) | 14.94 | 13.03 |
| P/E percentile, own 5-yr range | 59th | 72nd |
| P/B | 2.59 | 1.94 |
| Dividend yield | 1.11% | 1.07% |
| Profitability & growth | ||
| EPS (TTM) | 16.93 | 25.68 |
| Net profit (TTM) | $830.70M | $9.81B |
| Revenue (TTM) | $13.75B | $62.43B |
| Provider revenue period date | 2026-09-29 | 2026-09-29 |
| Revenue growth (YoY) | +9.2% | -0.1% |
| Gross margin | -- | -- |
| Operating margin | -- | -- |
| Net margin | 7.7% | 18.0% |
| Free cash flow (TTM) | $1.83B | $17.81B |
| Provider cash-flow period date | 2026-09-29 | 2026-09-29 |
| Ownership & sentiment | ||
| Institutional ownership | 101.2% | 91.4% |
| Insider activity (12mo) | 20 buy / 28 sell | 14 buy / 36 sell |
| Short interest (% of float) | 3.4% | 0.8% |
| Analyst consensus | 100% buy (5) | 29% buy / 64% hold / 7% sell (14) |
| Analyst price target | $352 (+11%) | $376 (+1%) |
| StockVane view | ||
| StockVane Quant Rating | C (84) | C (73) |
| Company | ||
| Employees | 14,800 | 45,000 |
| Founded | 1892 | 1985 |
▲ marks the more favourable stock(s) on measures with a clear direction (lower P/E, higher yield, higher Quant Rating, better 1-year return). Analyst consensus counts each covering institution once, at its most recent rating. Not a recommendation. Quant Rating method: Data & Methodology.